A new rule requires insurers to improve coverage of PrEP, which can prevent HIV, but Georgians face challenges getting the ...

The Trump administration has moved to stop the supply of lifesaving drugs for HIV, malaria, and tuberculosis in countries ...

The long-running HIV market rivalry between Gilead Sciences and GSK is about to turn a new page this year as Gilead looks to ...

As part of the foreign aid freeze by President Donald Trump, the U.S. distribution of HIV drugs in poor countries has been ...

A legally contested executive order on foreign aid did, at least initially, halt the distribution of life-saving HIV drugs.

Trump Administration Waives Halt on Distribution of HIV Medications Via PEPFAR By Stephanie Brown HealthDay Reporter WEDNESDAY, Jan. 29, 2025 (HealthDay News) -- The Trump administration has made some ...

Women living in rural Appalachia who are at high-risk of HIV had effective interventions delivered through Facebook.

HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...

Going forward, we may see more instances in which insurers deny or (temporarily) severely restrict coverage of accelerated ...

GSK launched a rare £2bn share buyback and raised its growth targets on the back of strong sales of speciality medicines including cancer and HIV drugs, sending shares up as much as 6 per cent on ...

The Trump administration has moved to stop the supply of lifesaving drugs for HIV, malaria and tuberculosis, as well as ...